Dimitris Repantis

2.8k total citations
26 papers, 932 citations indexed

About

Dimitris Repantis is a scholar working on Cognitive Neuroscience, Clinical Psychology and Organic Chemistry. According to data from OpenAlex, Dimitris Repantis has authored 26 papers receiving a total of 932 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cognitive Neuroscience, 10 papers in Clinical Psychology and 7 papers in Organic Chemistry. Recurrent topics in Dimitris Repantis's work include Neuroethics, Human Enhancement, Biomedical Innovations (9 papers), Psychedelics and Drug Studies (8 papers) and Chemical synthesis and alkaloids (7 papers). Dimitris Repantis is often cited by papers focused on Neuroethics, Human Enhancement, Biomedical Innovations (9 papers), Psychedelics and Drug Studies (8 papers) and Chemical synthesis and alkaloids (7 papers). Dimitris Repantis collaborates with scholars based in Germany, Netherlands and United States. Dimitris Repantis's co-authors include Isabella Heuser, Peter Schlattmann, Martin Dresler, Simone Kühn, Kathrin Ohla, Christoph Bublitz, Aleksandra Mroczko-Wąsowicz, Carlos Trenado, Anders Sandberg and Milan Scheidegger and has published in prestigious journals such as NeuroImage, Science Advances and Psychological Medicine.

In The Last Decade

Dimitris Repantis

24 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dimitris Repantis Germany 14 632 252 145 139 115 26 932
Haggai Sharon Israel 18 455 0.7× 159 0.6× 268 1.8× 214 1.5× 91 0.8× 57 1.0k
Aybala Sarıçiçek Türkiye 16 352 0.6× 180 0.7× 133 0.9× 75 0.5× 162 1.4× 19 756
Courtney Boyd United States 14 303 0.5× 150 0.6× 130 0.9× 268 1.9× 190 1.7× 27 992
Catherine Martelli France 16 503 0.8× 188 0.7× 54 0.4× 165 1.2× 206 1.8× 30 1.1k
Esther M. Opmeer Netherlands 18 534 0.8× 348 1.4× 123 0.8× 207 1.5× 101 0.9× 45 1.1k
Teddy J. Akiki United States 13 471 0.7× 102 0.4× 184 1.3× 252 1.8× 90 0.8× 25 864
Sara de la Salle Canada 18 451 0.7× 91 0.4× 116 0.8× 126 0.9× 150 1.3× 45 745
Anna Walter Switzerland 18 364 0.6× 304 1.2× 78 0.5× 85 0.6× 154 1.3× 24 889
Eiji Kirino Japan 18 782 1.2× 235 0.9× 64 0.4× 64 0.5× 76 0.7× 71 1.1k
Eva Grasa Spain 15 322 0.5× 263 1.0× 107 0.7× 366 2.6× 204 1.8× 57 974

Countries citing papers authored by Dimitris Repantis

Since Specialization
Citations

This map shows the geographic impact of Dimitris Repantis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitris Repantis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitris Repantis more than expected).

Fields of papers citing papers by Dimitris Repantis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitris Repantis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitris Repantis. The network helps show where Dimitris Repantis may publish in the future.

Co-authorship network of co-authors of Dimitris Repantis

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitris Repantis. A scholar is included among the top collaborators of Dimitris Repantis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitris Repantis. Dimitris Repantis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Repantis, Dimitris, et al.. (2025). Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review. Psychological Medicine. 55. e284–e284. 1 indexed citations
2.
Muthukumaraswamy, Suresh, Matthew J. Baggott, Eduardo Ekman Schenberg, et al.. (2025). Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design. Therapeutic Advances in Psychopharmacology. 15. 1967298386–1967298386.
3.
Bublitz, Christoph, et al.. (2025). Offering Psychedelic Treatments Before Assisted Dying for Psychiatric Conditions. JAMA Psychiatry. 82(8). 753–753.
4.
Repantis, Dimitris, et al.. (2024). Ethische Aspekte der Therapie mit Psychedelika. PUBLISSO (German National Library of Medicine). 69(2). 115–121. 2 indexed citations
5.
Repantis, Dimitris, et al.. (2024). Ethical Aspects of Psychedelic-Assisted Treatments: An Overview. Current topics in behavioral neurosciences. 2 indexed citations
6.
Repantis, Dimitris, et al.. (2022). Study protocol for “MDMA-assisted therapy as a treatment for major depressive disorder: A proof of principle study”. Frontiers in Psychiatry. 13. 954388–954388. 5 indexed citations
7.
Becker, Maxi, Dimitris Repantis, Martin Dresler, & Simone Kühn. (2022). Cognitive enhancement: Effects of methylphenidate, modafinil, and caffeine on latent memory and resting state functional connectivity in healthy adults. Human Brain Mapping. 43(14). 4225–4238. 14 indexed citations
8.
Langlitz, Nicolas, Erika Dyck, Milan Scheidegger, & Dimitris Repantis. (2021). Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics. Frontiers in Psychiatry. 12. 680064–680064. 24 indexed citations
9.
Bajbouj, Malek, Eric Hahn, Andreas Heinz, et al.. (2021). A Central Clearing Clinic to Provide Mental Health Services for Refugees in Germany. Frontiers in Public Health. 9. 635474–635474. 4 indexed citations
10.
Repantis, Dimitris, et al.. (2021). Memory enhancement with stimulants: Differential neural effects of methylphenidate, modafinil, and caffeine. A pilot study. Brain and Cognition. 154. 105802–105802. 2 indexed citations
11.
Repantis, Dimitris, et al.. (2020). Cognitive enhancement effects of stimulants: a randomized controlled trial testing methylphenidate, modafinil, and caffeine. Psychopharmacology. 238(2). 441–451. 34 indexed citations
12.
Müller, N., Boris N. Konrad, Marcel Pawlowski, et al.. (2016). Ghrelin modulates encoding-related brain function without enhancing memory formation in humans. NeuroImage. 142. 465–473. 21 indexed citations
13.
Repantis, Dimitris, et al.. (2016). Securing Opportunities for the Disadvantaged, or Medicalization Through the Back Door?. The American Journal of Bioethics. 16(6). 46–48. 2 indexed citations
14.
Fond, Guillaume, Jean‐Arthur Micoulaud‐Franchi, L. Brunel, et al.. (2015). Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review. Psychiatry Research. 229(1-2). 12–20. 31 indexed citations
15.
Kühn, Simone, et al.. (2015). Feeling smart: Effects of caffeine and glucose on cognition, mood and self-judgment. Physiology & Behavior. 151. 629–637. 42 indexed citations
16.
Forlini, Cynthia, Wayne Hall, Bruce Maxwell, et al.. (2013). Navigating the enhancement landscape. EMBO Reports. 14(2). 123–128. 17 indexed citations
17.
Dresler, Martin, Anders Sandberg, Kathrin Ohla, et al.. (2012). Non-pharmacological cognitive enhancement. Neuropharmacology. 64. 529–543. 117 indexed citations
18.
Repantis, Dimitris, et al.. (2010). Modafinil and methylphenidate for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research. 62(3). 187–206. 355 indexed citations
19.
Repantis, Dimitris, et al.. (2010). Acetylcholinesterase inhibitors and memantine for neuroenhancement in healthy individuals: A systematic review. Pharmacological Research. 61(6). 473–481. 106 indexed citations
20.
Repantis, Dimitris, et al.. (2008). Antidepressants for neuroenhancement in healthy individuals: a systematic review. 6(3-4). 139–174. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haggai Sharon Breakdown of academic impact, for papers by Aybala Sarıçiçek Breakdown of academic impact, for papers by Courtney Boyd Breakdown of academic impact, for papers by Catherine Martelli Breakdown of academic impact, for papers by Esther M. Opmeer Breakdown of academic impact, for papers by Teddy J. Akiki Breakdown of academic impact, for papers by Sara de la Salle Breakdown of academic impact, for papers by Anna Walter Breakdown of academic impact, for papers by Eiji Kirino Breakdown of academic impact, for papers by Eva Grasa
Rankless by CCL
2026